| Biotechnology Industry | Healthcare Sector | - CEO | XNSE Exchange | INE618N01014 ISIN |
| India Country | - Employees | 1 Jul 2022 Last Dividend | 30 May 2024 Last Split | - IPO Date |
Balaxi Pharmaceuticals Limited is a prominent entity primarily engaged in the international wholesale distribution of a diverse range of products, including pharmaceuticals, builders hardware, and fast-moving consumer goods (FMCG). The company boasts a widespread presence in several key regions, notably Africa, the Caribbean Islands, and Latin America. Originally established in the year 1942 and having its headquarters in Hyderabad, India, Balaxi Pharmaceuticals has evolved significantly over the decades. Initially known as Balaxi Ventures Limited, the company underwent a strategic rebranding in October 2020, adopting its current name to reflect its focused commitment towards the pharmaceutical sector. As a subsidiary of Balaxi Overseas Private Limited, it continues to expand its footprint, delivering essential products and services to a global clientele.
Balaxi Pharmaceuticals Limited offers a wide spectrum of products and services across various categories, including: